Hiroji Iwata

机构：Nagoya City University · ORCID：0000-0002-0242-4718

发表论文 851 篇 · 总被引 57193 次 · h-index 91

代表论文

• Patient-reported outcomes in the SERENA-6 trial of camizestrant plus CDK4/6 inhibitor in patients with advanced breast cancer and emergent ESR1 mutations during first-line endocrine-based therapy (2025 · Annals of Oncology · 被引 11)
• Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: results from the randomised, global phase III CAPItello-290 trial (2025 · Annals of Oncology · 被引 4)
• Association between adjuvant chemotherapy and outcomes in resected locoregional recurrence of hormone receptor-positive HER2-negative breast cancer: a multi-institutional retrospective study (2025 · ESMO Open · 被引 1)
• Supplementary Figure S4 from Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors (2026)
• Supplementary Figure S1 from Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors (2026)
• Supplementary Figure S5 from Comprehensive Genomic and Transcriptomic Characterization of MTAP Loss across Advanced Solid Tumors (2026)